← Leaderboards
Jon Marc Rhoads
University Of North Carolina Chapel Hill
$4,279,993
Attributed
$5,112,763
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $733K · FY2008–23$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,112,763 · 7
By mechanism
R01$3,853,214 · 2
R34$683,003 · 1
U01$391,296 · 1
R03$145,250 · 1
R21$40,000 · 1
M01$0 · 1
Top collaborators
- Yuying Liu5 shared
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Desmond Kimo Runyan$4,638,916
Others in their field
Top investigators on “Probiotics”
- Gary Fanger · Rise Therapeutics, Llc$26,547,866
- Sarkis K Mazmanian · California Institute Of Technology$10,460,394
- Sabita Roy · University Of Minnesota Twin Cities$9,108,304
- Joel Palefsky · University Of California San Francisco$8,712,471
- Phillip I Tarr · Seattle Children'S Hospital$8,647,804
- Tal Danino · Columbia Univ New York Morningside$8,217,641
Research focus
ProbioticsGastrointestinalInfantAdultSafetyDoseInflammatory Disease Of The IntestineAffectIntestinesInflammationAbdominal ColicBacteriaGastrointestinal DiseasesProductionBloodLactobacillusSeveritiesIncidenceFuturePlacebosBiological MarkersFecesIntestinal DiseasesComplex
Grant awards (20)
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder$492,019
R01 · FY2023 · HD · contact PI
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder$418,632
R01 · FY2022 · HD · contact PI
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder$434,917
R01 · FY2021 · HD · contact PI
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder$416,951
R01 · FY2019 · HD · contact PI
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder$425,155
R01 · FY2018 · HD · contact PI
Mechanisms of L. reuteri in regulating intestinal inflammation$307,800
R01 · FY2018 · AT · contact PI
Mechanisms of L. reuteri in regulating intestinal inflammation$342,000
R01 · FY2017 · AT · contact PI
Mechanisms of L. reuteri in regulating intestinal inflammation$342,000
R01 · FY2016 · AT · contact PI
Mechanisms of L. reuteri in regulating intestinal inflammation$331,740
R01 · FY2015 · AT · contact PI
Mechanisms of L. reuteri in regulating intestinal inflammation$342,000
R01 · FY2014 · AT · contact PI
Safety and Effect of L. reuteri on Biomarkers of Inflammation in Healthy Infants$259,767
R34 · FY2014 · AT · contact PI
Safety and Effect of L. reuteri on Biomarkers of Inflammation in Healthy Infants$309,236
R34 · FY2013 · AT · contact PI
Safety and Effect of L. reuteri on Biomarkers of Inflammation in Healthy Infants$114,000
R34 · FY2012 · AT · contact PI
Phase I: Safety and Tolerance of Lactobactocillus reuteri in Adults$48,976
U01 · FY2011 · AT · contact PI
Phase I: Safety and Tolerance of Lactobactocillus reuteri in Adults$114,028
U01 · FY2010 · AT · contact PI
Phase I: Safety and Tolerance of Lactobactocillus reuteri in Adults$228,292
U01 · FY2009 · AT · contact PI
Effect of Lactobactocillus Rhamnosus GG on Colic Symptoms and Breath Hydrogen$40,000
R21 · FY2008 · AT · contact PI
MECHANISMS OF INTESTINAL CELL MIGRATION$72,750
R03 · FY2001 · DK
MECHANISMS OF INTESTINAL CELL MIGRATION$72,500
R03 · FY2000 · DK
LAMIVUDINE TRAIAL IN PEDIATRIC PTS W/ CHRONIC HEPATITIS B$0
M01 · FY2000 · RR